Clinical Trials Logo

Diabetic Foot Ulcers clinical trials

View clinical trials related to Diabetic Foot Ulcers.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06189638 Not yet recruiting - Clinical trials for Diabetic Foot Ulcers

Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers

PL-5
Start date: January 8, 2024
Phase: Phase 2
Study type: Interventional

This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study to evaluate the clinical efficacy and safety of Antimicrobial Peptide PL-5 Topical Spray in patients with mild infections of diabetic foot ulcers. Eligible subjects will be randomized (1:1:1) to receive twice a day, 14 days treatment of Antimicrobial Peptide PL-5 Topical Spray (1‰), Antimicrobial Peptide PL-5 Topical Spray (2‰) and topical placebo (vehicle) spray. In this study, the cut-off date for final analysis is defined as the time when all subjects have completed the last visit or discontinued the study

NCT ID: NCT02691234 Not yet recruiting - Clinical trials for Diabetic Foot Ulcers

Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers

Start date: April 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Low intensity shockwaves for treating diabetic foot ulcers (DFUs) have been in evaluation for the past 5 years. Many researchers showed the effectiveness of Low intensity shockwaves of in accelerating the healing rate of non-ischemic chronic DFUs. Wang et al. showed, the use of Low intensity shockwaves on DFUs, significantly improved topical blood flow perfusion rate, increased cell proliferation and cell activity and decreased cell apoptosis. The present study deals with the effect of low intensity shockwaves on DFUs. Shockwave treatment will be done together with the standard conventional treatment for DFUs, compared to a control group who will receive the same conventional standard of care.

NCT ID: NCT02672280 Not yet recruiting - Burns Clinical Trials

Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects

SEESCMMSCTSD
Start date: May 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the present study is to evaluate the safety and exploratory efficacy of the medical collagen membrane with umbilical cord derived mesenchymal stem cells in the treatment of patients with skin defects.

NCT ID: NCT00916292 Not yet recruiting - Clinical trials for Diabetic Foot Ulcers

Safety Study of Topical Human FGF-1 for Wound Healing

Start date: November 2012
Phase: Phase 1
Study type: Interventional

The purpose of the study is to see if FGF-1 is safe when applied topically to the surface of a wound.